Register entry
ZHEJIANG LEPU PHARMACETICAL CO., LTD.
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 0
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Pazopanib Hydrochloride | powder | 68578-0015BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
Compare
Other companies listing pazopanib hydrochloride
- Granules Pharmaceuticals Inc.8 sites · 302 NDC
- MSN Laboratories Private Limited,8 sites · 275 NDC
- Hetero Labs Limited8 sites · 167 NDC
- Medichem SA5 sites · 43 NDC
- Sionc Pharmaceuticals Private Limited2 sites · 56 NDC
- Formosa Laboratories, Inc.1 site · 33 NDC
- Medichem Manufacturing (Malta) Ltd.0 sites · 17 NDC
Enquiry
Common questions
- Is ZHEJIANG LEPU PHARMACETICAL CO., LTD. FDA approved?
- ZHEJIANG LEPU PHARMACETICAL CO., LTD. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does ZHEJIANG LEPU PHARMACETICAL CO., LTD. make?
- 1 product is listed under ZHEJIANG LEPU PHARMACETICAL CO., LTD. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.